Funding Rounds
PathoQuest

PathoQuest Series B (2021, $17M)

PathoQuest

Biotech solution providing NGS-based metagenomic tests to fully identify pathogens.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $17.31M

Raised Date: 2021-01-01

Investors